Oxytocin Tracker App

Intranasal oxytocin clinical research doses range from 16 IU to 40 IU per session. The most common doses used in published trials: 24 IU (3 sprays of 8 IU/spray) — used in many early social cognition studies; 40 IU (4 sprays of 10 IU/spray) — the most common dose in current trials for social anxiety, autism, and PTSD; 20 IU (2 sprays of 10 IU/spray) — a lower dose used in more sensitive populations or as a starting dose. Commercial oxytocin nasal sprays (compounded) are typically prepared at 10 IU/spray (0.1 mL per spray), with standard bottles delivering 2–4 sprays per dose. Important technique: alternating nostrils with each spray and remaining upright for 10–15 minutes after administration improves delivery. Onset varies by individual: most users feel effects within 15–30 minutes. When tracking in Shotlee, always log the IU amount per dose and the spray count to distinguish formulation differences across batches. Effects are situational — oxytocin enhances processing of social stimuli that are present, so taking it without social interaction produces minimal subjective effect. Time doses for 20–30 minutes before the relevant social event or situation.

Tolerance to intranasal oxytocin is a genuine concern with frequent use. OT receptors (OXTR) can downregulate with chronic high-dose stimulation — similar to receptor desensitization observed with other neuropeptides. Evidence from research: animal studies show chronic oxytocin administration reduces OXTR binding capacity and baseline social behavior. Human data on IN-OT tolerance is limited, but clinical experience suggests: (1) Tolerance risk increases with daily use at higher doses (40 IU/day or more). (2) Intermittent use (1–3x weekly, situationally rather than scheduled) appears to preserve sensitivity. (3) Paradoxical effects (increased anxiety or reduced social comfort) sometimes emerge with overuse — a potential sign of receptor downregulation. Recommendations for minimizing tolerance: use oxytocin situationally rather than daily; take regular breaks (1–2 weeks off per month); use the minimum effective dose (start at 20 IU rather than 40); avoid combining with other social anxiolytics daily. When tracking in Shotlee, logging subjective effects per dose over time is the best way to detect tolerance development — a pattern of declining social ease and anxiety reduction scores at the same dose indicates it may be time for a use break.

Open the Shotlee app, navigate to the dose logging screen, select Oxytocin as your medication, and enter the dose amount, injection site, and time. Shotlee stores all entries with timestamps and lets you view your complete dose history, adherence rate, and missed dose alerts. The app is free to download and use.

The most important side effects to track include gastrointestinal symptoms (nausea, vomiting, diarrhea, constipation), injection site reactions, appetite changes, energy levels, and any unusual symptoms. Log these daily in Shotlee so you can share accurate trend data with your healthcare provider at your next visit.

Most patients begin noticing appetite changes within the first one to two weeks. Measurable weight loss typically becomes apparent by weeks four to eight, depending on the dose titration schedule and individual metabolic response. Track your weekly weight in Shotlee to visualize your personal response curve over time.

Download Shotlee for free from the App Store, create your profile, and navigate to the dose logging screen. Select Oxytocin as your medication, then begin logging each dose with the exact amount, time, and injection site. Shotlee will automatically generate trend charts and adherence reports from your entries, giving you and your healthcare provider clear visibility into your protocol progress.

The highest-value metrics to track are: dose amount and timing for adherence monitoring, daily side effect type and severity for tolerability assessment, weekly fasting body weight under consistent conditions for efficacy tracking, waist circumference and body measurements for composition changes, lab results including metabolic panels and lipid profiles for safety monitoring, and daily appetite and energy ratings for subjective response assessment. Shotlee supports all of these in a single integrated dashboard.

Yes. Shotlee generates comprehensive reports from your tracking data that you can share with your healthcare provider during appointments. Having objective longitudinal data — rather than relying on memory — enables more efficient clinical consultations, more personalized dose adjustments, and better overall treatment outcomes. Many users find that sharing their Shotlee data significantly improves the quality of their provider interactions.